tiprankstipranks
Cochlear Limited (CHEOF)
OTHER OTC:CHEOF
US Market
CHEOF
Cochlear
RESEARCH TOOLSreports

Cochlear (CHEOF) Stock Forecast & Price Target

32 Followers
See the Price Targets and Ratings of:

CHEOF Analyst Ratings

Hold
12Ratings
Hold
3 Buy
8 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Cochlear
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CHEOF Stock 12 Month Forecast

Average Price Target

$95.54
▼(-22.82% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is $95.54 with a high forecast of $154.49 and a low forecast of $68.01. The average price target represents a -22.82% change from the last price of $123.78.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"67":"$67","101":"$101","135":"$135","169":"$169","203":"$203"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":154.49122,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$154.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95.53815663636362,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$95.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.0105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$68.01</span>\n  </div></div>","useHTML":true}}],"tickPositions":[67,101,135,169,203],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.54,78.84394,85.14788,91.45182,97.75576000000001,104.05969999999999,110.36364,116.66758,122.97152,129.27546,135.5794,141.88333999999998,148.18728,{"y":154.49122,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.54,74.30908897202798,76.07817794405595,77.84726691608392,79.61635588811188,81.38544486013986,83.15453383216783,84.9236228041958,86.69271177622377,88.46180074825175,90.23088972027972,91.99997869230768,93.76906766433565,{"y":95.53815663636362,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.54,72.19157692307692,71.84315384615385,71.49473076923077,71.1463076923077,70.79788461538462,70.44946153846153,70.10103846153847,69.75261538461538,69.4041923076923,69.05576923076923,68.70734615384615,68.35892307692308,{"y":68.0105,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":173.321,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.147,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.535,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":202.511,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.794,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":187.808,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":188.978,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.462,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.793,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.741,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.665,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.54,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$154.49Average Price Target$95.54Lowest Price Target$68.01
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on CHEOF
David Low
UBS
UBS
―
Hold
―
Downgraded
05/01/26
UBS downgrades Cochlear (CHEOF) to a Hold
Canaccord Genuity Analyst forecast on CHEOF
Shane Storey
Canaccord Genuity
Canaccord Genuity
$211.19→$85.91
Buy
-30.60%
Downside
Reiterated
04/29/26
Canaccord Genuity Reaffirms Their Buy Rating on Cochlear (CHEOF)
J.P. Morgan Analyst forecast on CHEOF
Chris Cooper
J.P. Morgan
J.P. Morgan
$79.46
Hold
-35.80%
Downside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Cochlear (Other OTC: CHEOF) and Boston Scientific (NYSE: BSX)
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$160.36→$110.25
Hold
-10.93%
Downside
Reiterated
04/23/26
Ord Minnett Sticks to Their Hold Rating for Cochlear (CHEOF)
Jefferies Analyst forecast on CHEOF
David Stanton
Jefferies
Jefferies
$204.03→$98.08
Buy
-20.76%
Downside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), Cochlear (Other OTC: CHEOF) and Definium Therapeutics (NASDAQ: DFTX)
Morgan Stanley Analyst forecast on CHEOF
David Bailey
Morgan Stanley
Morgan Stanley
$138.88→$85.19
Hold
-31.17%
Downside
Upgraded
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cochlear (Other OTC: CHEOF), CervoMed (NASDAQ: CRVO) and Community Health (NYSE: CYH)
Morgans Analyst forecast on CHEOF
Derek Jellinek
Morgans
Morgans
$153.87→$76.72
Hold
-38.02%
Downside
Reiterated
04/23/26
Cochlear (CHEOF) Gets a Hold from Morgans
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$171.1→$82.33
Hold
-33.49%
Downside
Reiterated
04/22/26
Macquarie Sticks to Their Hold Rating for Cochlear (CHEOF)
Jarden Analyst forecast on CHEOF
Steven Wheen
Jarden
Jarden
$160.36→$120.99
Hold
-2.26%
Downside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)
Citi Analyst forecast on CHEOF
Laura Sutcliffe
Citi
Citi
$150.34→$68.01
Sell
-45.06%
Downside
Downgraded
04/22/26
Cochlear Downgraded to Sell on Structurally Weaker Growth, Demand Risks, and Margin Pressure
RBC Capital Analyst forecast on CHEOF
Craig Wong-Pan
RBC Capital
RBC Capital
$212.62→$89.49
Buy
-27.70%
Downside
Reiterated
04/22/26
RBC Capital Keeps Their Buy Rating on Cochlear (CHEOF)
Goldman Sachs Analyst forecast on CHEOF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$175.32→$154.49
Hold
24.81%
Upside
Reiterated
03/13/26
Goldman Sachs Keeps Their Hold Rating on Cochlear (CHEOF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on CHEOF
David Low
UBS
UBS
―
Hold
―
Downgraded
05/01/26
UBS downgrades Cochlear (CHEOF) to a Hold
Canaccord Genuity Analyst forecast on CHEOF
Shane Storey
Canaccord Genuity
Canaccord Genuity
$211.19→$85.91
Buy
-30.60%
Downside
Reiterated
04/29/26
Canaccord Genuity Reaffirms Their Buy Rating on Cochlear (CHEOF)
J.P. Morgan Analyst forecast on CHEOF
Chris Cooper
J.P. Morgan
J.P. Morgan
$79.46
Hold
-35.80%
Downside
Reiterated
04/24/26
Analysts Offer Insights on Healthcare Companies: Cochlear (Other OTC: CHEOF) and Boston Scientific (NYSE: BSX)
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$160.36→$110.25
Hold
-10.93%
Downside
Reiterated
04/23/26
Ord Minnett Sticks to Their Hold Rating for Cochlear (CHEOF)
Jefferies Analyst forecast on CHEOF
David Stanton
Jefferies
Jefferies
$204.03→$98.08
Buy
-20.76%
Downside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), Cochlear (Other OTC: CHEOF) and Definium Therapeutics (NASDAQ: DFTX)
Morgan Stanley Analyst forecast on CHEOF
David Bailey
Morgan Stanley
Morgan Stanley
$138.88→$85.19
Hold
-31.17%
Downside
Upgraded
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cochlear (Other OTC: CHEOF), CervoMed (NASDAQ: CRVO) and Community Health (NYSE: CYH)
Morgans Analyst forecast on CHEOF
Derek Jellinek
Morgans
Morgans
$153.87→$76.72
Hold
-38.02%
Downside
Reiterated
04/23/26
Cochlear (CHEOF) Gets a Hold from Morgans
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$171.1→$82.33
Hold
-33.49%
Downside
Reiterated
04/22/26
Macquarie Sticks to Their Hold Rating for Cochlear (CHEOF)
Jarden Analyst forecast on CHEOF
Steven Wheen
Jarden
Jarden
$160.36→$120.99
Hold
-2.26%
Downside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)
Citi Analyst forecast on CHEOF
Laura Sutcliffe
Citi
Citi
$150.34→$68.01
Sell
-45.06%
Downside
Downgraded
04/22/26
Cochlear Downgraded to Sell on Structurally Weaker Growth, Demand Risks, and Margin Pressure
RBC Capital Analyst forecast on CHEOF
Craig Wong-Pan
RBC Capital
RBC Capital
$212.62→$89.49
Buy
-27.70%
Downside
Reiterated
04/22/26
RBC Capital Keeps Their Buy Rating on Cochlear (CHEOF)
Goldman Sachs Analyst forecast on CHEOF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$175.32→$154.49
Hold
24.81%
Upside
Reiterated
03/13/26
Goldman Sachs Keeps Their Hold Rating on Cochlear (CHEOF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

3 Months
Shane StoreyCanaccord Genuity
Success Rate
4/9 ratings generated profit
44%
Average Return
-5.14%
Copying Shane Storey's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -5.14% per trade.
1 Year
David StantonJefferies
Success Rate
3/9 ratings generated profit
33%
Average Return
-37.07%
Copying David Stanton's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -37.07% per trade.
2 Years
David StantonJefferies
Success Rate
2/9 ratings generated profit
22%
Average Return
-46.09%
Copying David Stanton's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -46.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CHEOF Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
3
5
5
2
Buy
6
6
8
3
3
Hold
10
10
14
9
8
Sell
2
3
3
2
1
Strong Sell
0
0
0
0
0
total
18
22
30
19
14
In the current month, CHEOF has received 5 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. CHEOF average Analyst price target in the past 3 months is 95.54.
Each month's total comprises the sum of three months' worth of ratings.

CHEOF Financial Forecast

CHEOF Earnings Forecast

Next quarter’s earnings estimate for CHEOF is $1.24 with a range of $1.13 to $1.36. The previous quarter’s EPS was $2.14. CHEOF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CHEOF has Performed in-line its overall industry.
Next quarter’s earnings estimate for CHEOF is $1.24 with a range of $1.13 to $1.36. The previous quarter’s EPS was $2.14. CHEOF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CHEOF has Performed in-line its overall industry.

CHEOF Sales Forecast

Next quarter’s sales forecast for CHEOF is $844.63M with a range of $797.24M to $910.25M. The previous quarter’s sales results were $842.88M. CHEOF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CHEOF has Performed in-line its overall industry.
Next quarter’s sales forecast for CHEOF is $844.63M with a range of $797.24M to $910.25M. The previous quarter’s sales results were $842.88M. CHEOF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CHEOF has Performed in-line its overall industry.

CHEOF Stock Forecast FAQ

What is CHEOF’s average 12-month price target, according to analysts?
Based on analyst ratings, Cochlear Limited’s 12-month average price target is 95.54.
    What is CHEOF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CHEOF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CHEOF a Buy, Sell or Hold?
        Cochlear Limited has a consensus rating of Hold which is based on 3 buy ratings, 8 hold ratings and 1 sell ratings.
          What is Cochlear Limited’s price target?
          The average price target for Cochlear Limited is 95.54. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $154.49 ,the lowest forecast is $68.01. The average price target represents -22.82% Decrease from the current price of $123.78.
            What do analysts say about Cochlear Limited?
            Cochlear Limited’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of CHEOF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.